Brief: Phreesia Q2 Revenue USD 117.255 Million Vs. IBES Estimate USD 116.5 Million

Phreesia

04/09/2025 21:05

Overview

Phreesia fiscal Q2 2026 rev grows 15% yr/yr, beating analyst expectations, per LSEG data

Company achieves first-ever net income positive quarter

Co announces agreement to acquire AccessOne, expanding payment solutions

Outlook

Phreesia maintains fiscal 2026 revenue outlook at $472 mln to $482 mln

Company updates fiscal 2026 Adjusted EBITDA outlook to $87 mln to $92 mln

Phreesia expects AHSCs to reach approximately 4,500 in fiscal 2026

Company anticipates increase in total revenue per AHSC for fiscal 2026

Result Drivers

REVENUE GROWTH - Total revenue increased by 15% yr/yr to $117.3 mln, driven by a 7% increase in the average number of healthcare services clients and a 7% rise in total revenue per client

NET INCOME TURNAROUND - Achieved first-ever net income positive quarter with $0.7 mln, compared to a net loss of $18 mln in the same period last yr

ACCESSONE ACQUISITION - Entered into a definitive agreement to acquire AccessOne, a leader in healthcare receivables financing solutions, to expand payment solutions offerings

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$117.26 mln
$116.50 mln (16 Analysts)
Q2 Net Income
$654,000


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the software peer group is "buy"

Wall Street's median 12-month price target for Phreesia Inc is $32.50, about 6.3% above its September 3 closing price of $30.44

Press Release: ID:nBw6QgjrKa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)